Vogel, Charles L.

University of Southern California · Kaiser Permanente · University of Miami · University of California, Los Angeles · University of California, San Francisco · Genentech

2 papers on CoChat

Most cited papers

Verified
Efficacy and Safety of Trastuzumab as a Single Agent in First-Line Treatment of HER2-Overexpressing Metastatic Breast Cancer
Vogel, C. L., Cobleigh, M. A., Tripathy, D., Gutheil, J. C., Harris, L. N., Fehrenbacher, L., Slamon, D. J., Murphy, M., Novotny, W. F., Burchmore, M., et al. (2002) · Journal of Clinical Oncology
HER2/EGFR in Cancer ResearchGastric Cancer Management and Outcomes
Cited by 1,860
Verified
Anastrozole, a potent and selective aromatase inhibitor, versus megestrol acetate in postmenopausal women with advanced breast cancer: results of overview analysis of two phase III trials. Arimidex Study Group.
Buzdar, A., Jonat, W., Howell, A., Jones, S. E., Blomqvist, C., Vogel, C. L., Eiermann, W., Wolter, J. M., Azab, M., Webster, A., et al. (1996) · Journal of Clinical Oncology
Breast Cancer Treatment StudiesAdvanced Breast Cancer Therapies
Cited by 406

Go further with a free account

Verify every reference, keep papers in a library, and ask questions across them.

Sign up - it is free